202 related articles for article (PubMed ID: 28315369)
41. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway.
Hwang JT; Kwak DW; Lin SK; Kim HM; Kim YM; Park OJ
Ann N Y Acad Sci; 2007 Jan; 1095():441-8. PubMed ID: 17404056
[TBL] [Abstract][Full Text] [Related]
42. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
Lin CJ; Cheng LC; Lin TC; Wang CJ; Li LA
Biochem Pharmacol; 2014 Aug; 90(3):288-96. PubMed ID: 24875446
[TBL] [Abstract][Full Text] [Related]
43. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
[TBL] [Abstract][Full Text] [Related]
44. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
45. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer.
Liu H; Ma L; Lin J; Cao B; Qu D; Luo C; Huang W; Han L; Xu H; Wu Z; Xu R; Zhang D
Pharmacol Res; 2020 May; 155():104738. PubMed ID: 32151681
[TBL] [Abstract][Full Text] [Related]
46. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
47. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.
Azios NG; Dharmawardhane SF
Neoplasia; 2005 Feb; 7(2):128-40. PubMed ID: 15802018
[TBL] [Abstract][Full Text] [Related]
48. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells.
Wang Y; Miao H; Li W; Yao J; Sun Y; Li Z; Zhao L; Guo Q
Biochem Pharmacol; 2014 Aug; 90(3):212-25. PubMed ID: 24858801
[TBL] [Abstract][Full Text] [Related]
49. Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.
Venkatadri R; Muni T; Iyer AK; Yakisich JS; Azad N
Cell Death Dis; 2016 Feb; 7(2):e2104. PubMed ID: 26890143
[TBL] [Abstract][Full Text] [Related]
50. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling.
Scarlatti F; Sala G; Somenzi G; Signorelli P; Sacchi N; Ghidoni R
FASEB J; 2003 Dec; 17(15):2339-41. PubMed ID: 14563682
[TBL] [Abstract][Full Text] [Related]
51. Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines.
Chimento A; Sala M; Gomez-Monterrey IM; Musella S; Bertamino A; Caruso A; Sinicropi MS; Sirianni R; Puoci F; Parisi OI; Campana C; Martire E; Novellino E; Saturnino C; Campiglia P; Pezzi V
Bioorg Med Chem Lett; 2013 Dec; 23(23):6401-5. PubMed ID: 24119558
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of Resveratrol Derivatives and In Vitro Screening for Potential Cancer Chemopreventive Activities.
Orsini F; Verotta L; Klimo K; Gerhäuser C
Arch Pharm (Weinheim); 2016 Jun; 349(6):414-27. PubMed ID: 27159630
[TBL] [Abstract][Full Text] [Related]
53. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
54. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.
Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y
Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896
[TBL] [Abstract][Full Text] [Related]
55. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.
Li QQ; Xu JD; Wang WJ; Cao XX; Chen Q; Tang F; Chen ZQ; Liu XP; Xu ZD
Clin Cancer Res; 2009 Apr; 15(8):2657-65. PubMed ID: 19336515
[TBL] [Abstract][Full Text] [Related]
56. Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor.
Connor CE; Norris JD; Broadwater G; Willson TM; Gottardis MM; Dewhirst MW; McDonnell DP
Cancer Res; 2001 Apr; 61(7):2917-22. PubMed ID: 11306468
[TBL] [Abstract][Full Text] [Related]
57. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1.
Shi Y; Yang S; Troup S; Lu X; Callaghan S; Park DS; Xing Y; Yang X
Oncol Rep; 2011 Jun; 25(6):1713-9. PubMed ID: 21479363
[TBL] [Abstract][Full Text] [Related]
59. Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro.
Chen FP; Chien MH
Climacteric; 2014 Dec; 17(6):682-91. PubMed ID: 24978400
[TBL] [Abstract][Full Text] [Related]
60. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
